Publisher Correction: Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children.

Autor: Zhong Y; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore. youjiazhong@nus.edu.sg.; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. youjiazhong@nus.edu.sg.; Khoo Teck Puat-National University Children's Medical Institute, National University Health System (NUHS), Singapore, Singapore. youjiazhong@nus.edu.sg., Kang AYH; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore., Tay CJX; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore., Li HE; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore., Elyana N; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore., Tan CW; Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Yap WC; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.; Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lim JME; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Le Bert N; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Chan KR; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Ong EZ; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore., Low JG; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore., Shek LP; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore.; Khoo Teck Puat-National University Children's Medical Institute, National University Health System (NUHS), Singapore, Singapore., Tham EH; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore.; Khoo Teck Puat-National University Children's Medical Institute, National University Health System (NUHS), Singapore, Singapore., Ooi EE; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. engeong.ooi@duke-nus.edu.sg.; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore. engeong.ooi@duke-nus.edu.sg.; Department of Clinical Translational Research, Singapore General Hospital, Singapore, Singapore. engeong.ooi@duke-nus.edu.sg.

Publikováno v: Nature medicine [Nat Med] 2024 Jul; Vol. 30 (7), pp. 2093.

IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled Trial.

Autor: Low JG; Department of Infectious Diseases, Singapore General Hospital, Singapore.; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Oh HM; Changi General Hospital, Singapore., Leo YS; National Centre for Infectious Diseases, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore., Kalimuddin S; Department of Infectious Diseases, Singapore General Hospital, Singapore.; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Wijaya L; Department of Infectious Diseases, Singapore General Hospital, Singapore., Pang J; National Centre for Infectious Diseases, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.; SingHealth Duke-NUS Global Health Institute, Duke-NUS Medical School, Singapore., Lee TH; Tan Tock Seng Hospital, Singapore., Moss KJ; Takeda Development Center Americas, Inc., Cambridge, Massachusetts., Brose M; Takeda Development Center Americas, Inc., Cambridge, Massachusetts., Tricou V; Takeda Pharmaceuticals International AG, Zurich, Switzerland.

Publikováno v: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2024 May 28; Vol. 111 (1), pp. 102-106. Date of Electronic Publication: 2024 May 28 (Print Publication: 2024).

Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19.

Autor: Tan JY; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Anderson DE; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.; Victorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia., Rathore AP; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA., O'Neill A; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Mantri CK; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Saron WA; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Lee CQ; Duke-NUS Medical School, Program in Cardiovascular and Metabolic Disorders, Singapore., Cui CW; Duke-NUS Medical School, Program in Cardiovascular and Metabolic Disorders, Singapore., Kang AE; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Foo R; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Kalimuddin S; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.; Department of Infectious Diseases, Singapore General Hospital, Singapore., Low JG; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.; Department of Infectious Diseases, Singapore General Hospital, Singapore., Ho L; Duke-NUS Medical School, Program in Cardiovascular and Metabolic Disorders, Singapore., Tambyah P; Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Division of Infectious Disease, University Medicine Cluster, National University Hospital, Singapore., Burke TW; Center for Applied Genomics and Precision Medicine, Duke University Medical Center, Durham, North Carolina, USA., Woods CW; Center for Applied Genomics and Precision Medicine, Duke University Medical Center, Durham, North Carolina, USA.; Division of Infectious Diseases, Duke University Medical Center, Durham VA Medical Center, Durham, North Carolina, USA., Chan KR; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Karhausen J; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.; Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA., St John AL; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.; Department of Microbiology and Immunology, National University of Singapore, Singapore.; SingHealth Duke-NUS Global Health Institute, Singapore.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2023 Oct 02; Vol. 133 (19). Date of Electronic Publication: 2023 Oct 02.

RNase2 is a possible trigger of acute-on-chronic inflammation leading to mRNA vaccine-associated cardiac complication.

Autor: Ong EZ; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore., Koh CWT; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Tng DJH; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore., Ooi JSG; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Yee JX; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore., Chew VSY; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore., Leong YS; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore., Gunasegaran K; National Heart Centre, Singapore, Singapore., Yeo CP; Department of Pathology, Singapore General Hospital, Singapore, Singapore., Oon LLE; Department of Pathology, Singapore General Hospital, Singapore, Singapore., Sim JXY; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore., Chan KR; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. Electronic address: kuanrong.chan@duke-nus.edu.sg., Low JG; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore. Electronic address: jenny.low@singhealth.com.sg., Ooi EE; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore. Electronic address: engeong.ooi@duke-nus.edu.sg.

Publikováno v: Med (New York, N.Y.) [Med] 2023 Jun 09; Vol. 4 (6), pp. 353-360.e2. Date of Electronic Publication: 2023 Apr 26.

A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine.

Autor: Low JG; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.; Department of Infectious Diseases, Singapore General Hospital, 169608, Singapore, Singapore.; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore., de Alwis R; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore., Chen S; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore., Kalimuddin S; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.; Department of Infectious Diseases, Singapore General Hospital, 169608, Singapore, Singapore., Leong YS; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore., Mah TKL; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore., Yuen N; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore.; Department of Biological Sciences, Nanyang Technological University, 639798, Singapore, Singapore., Tan HC; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore., Zhang SL; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore., Sim JXY; Department of Infectious Diseases, Singapore General Hospital, 169608, Singapore, Singapore., Chan YFZ; Department of Infectious Diseases, Singapore General Hospital, 169608, Singapore, Singapore., Syenina A; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore., Yee JX; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore., Ong EZ; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore., Sekulovich R; Arcturus Therapeutics Inc, San Diego, CA, 92121, USA., Sullivan BB; Arcturus Therapeutics Inc, San Diego, CA, 92121, USA., Lindert K; Arcturus Therapeutics Inc, San Diego, CA, 92121, USA., Sullivan SM; Arcturus Therapeutics Inc, San Diego, CA, 92121, USA., Chivukula P; Arcturus Therapeutics Inc, San Diego, CA, 92121, USA., Hughes SG; Arcturus Therapeutics Inc, San Diego, CA, 92121, USA. drstevehughes@gmail.com., Ooi EE; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2022 Dec 13; Vol. 7 (1), pp. 161. Date of Electronic Publication: 2022 Dec 13.